Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00298974 · ClinicalTrials.gov registry record · Phase 3
A Study of Pain Relief in Osteoarthritis
A Phase 3 study, sponsored by Abbott.
- Completed
- Registry status
- Phase 3
- Development phase
- 873
- Enrollment target
NCT00298974 is a Phase 3 study that has completed, run by Abbott. The registered enrollment target is 873 participants.
The verdict
NCT00298974, a Phase 3 study, has completed, sponsored by Abbott.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 873 participants
- Enrollment target
Study Summary
The purpose of this study is to compare the safety and pain-relieving ability of Vicodin CR to placebo in subjects with osteoarthritis (OA) of the hip or knee.
Interventions
- DRUG Placebo
- DRUG hydrocodone / acetaminophen extended release
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 873 participants |
| Start Date | 2006-02 |
| Est. Completion | 2007-05 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00298974
The ClinicalTrials.gov registry entry for NCT00298974 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 873 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Abbott, which has 181 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT00298974 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00298974 about?
NCT00298974 is a clinical study titled "A Study of Pain Relief in Osteoarthritis". The purpose of this study is to compare the safety and pain-relieving ability of Vicodin CR to placebo in subjects with osteoarthritis (OA) of the hip or knee.
What is the current status of trial NCT00298974?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 873 participants. The study started on 2006-02. Estimated completion is 2007-05.
What interventions are being tested in trial NCT00298974?
The interventions under investigation include: Placebo (DRUG), hydrocodone / acetaminophen extended release (DRUG).
Who is sponsoring clinical trial NCT00298974?
This trial is sponsored by Abbott, which has 181 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.